
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of photocontrolled BRD4 PROTACs for tongue squamous cell carcinoma (TSCC)
Zhenzhen Li, Siyue Ma, Xingye Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113608-113608
Closed Access | Times Cited: 31
Zhenzhen Li, Siyue Ma, Xingye Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 222, pp. 113608-113608
Closed Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Chemistries of bifunctional PROTAC degraders
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 175
Chao-Guo Cao, Ming He, Liguo Wang, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 16, pp. 7066-7114
Closed Access | Times Cited: 175
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
Ming He, Chao-Guo Cao, Zhihao Ni, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 174
Ming He, Chao-Guo Cao, Zhihao Ni, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 174
Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
Claudia J. Diehl, Alessio Ciulli
Chemical Society Reviews (2022) Vol. 51, Iss. 19, pp. 8216-8257
Open Access | Times Cited: 127
Claudia J. Diehl, Alessio Ciulli
Chemical Society Reviews (2022) Vol. 51, Iss. 19, pp. 8216-8257
Open Access | Times Cited: 127
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 74
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 74
Self-Assembled Nano-PROTAC Enables Near-Infrared Photodynamic Proteolysis for Cancer Therapy
Weishan Wang, Chenghong Zhu, Bin Zhang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 30, pp. 16642-16649
Closed Access | Times Cited: 46
Weishan Wang, Chenghong Zhu, Bin Zhang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 30, pp. 16642-16649
Closed Access | Times Cited: 46
PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 21
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 21
Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
Jing Gao, Lei Yang, Shumin Lei, et al.
Science Bulletin (2023) Vol. 68, Iss. 10, pp. 1069-1085
Closed Access | Times Cited: 35
Jing Gao, Lei Yang, Shumin Lei, et al.
Science Bulletin (2023) Vol. 68, Iss. 10, pp. 1069-1085
Closed Access | Times Cited: 35
Ligation to Scavenging Strategy Enables On-Demand Termination of Targeted Protein Degradation
Yuhui Jin, Jing Fan, Ruyan Wang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 13, pp. 7218-7229
Closed Access | Times Cited: 23
Yuhui Jin, Jing Fan, Ruyan Wang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 13, pp. 7218-7229
Closed Access | Times Cited: 23
Digesting the Role of JAK-STAT and Cytokine Signaling in Oral and Gastric Cancers
Yanhong Ni, Jun T. Low, John Silke, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Yanhong Ni, Jun T. Low, John Silke, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Progress in the controllability technology of PROTAC
Xin He, Zhibing Weng, Yi Zou
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116096-116096
Closed Access | Times Cited: 18
Xin He, Zhibing Weng, Yi Zou
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116096-116096
Closed Access | Times Cited: 18
Photoswitchable PROTACs for Reversible and Spatiotemporal Regulation of NAMPT and NAD+
Junfei Cheng, Jing Zhang, Shipeng He, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 8
Junfei Cheng, Jing Zhang, Shipeng He, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 12
Closed Access | Times Cited: 8
Chemically induced degradation of epigenetic targets
Md Kabir, Xufen Yu, H. Ümit Kanıskan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 13, pp. 4313-4342
Open Access | Times Cited: 13
Md Kabir, Xufen Yu, H. Ümit Kanıskan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 13, pp. 4313-4342
Open Access | Times Cited: 13
TACkling Cancer by Targeting Selective Protein Degradation
María del Mar Noblejas‐López, David Tébar-García, Raquel López-Rosa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2442-2442
Open Access | Times Cited: 11
María del Mar Noblejas‐López, David Tébar-García, Raquel López-Rosa, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2442-2442
Open Access | Times Cited: 11
A comprehensive review of BET-targeting PROTACs for cancer therapy
Xiaoli Zhou, Fang Zhao, Yong-Tao Xu, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117033-117033
Closed Access | Times Cited: 17
Xiaoli Zhou, Fang Zhao, Yong-Tao Xu, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117033-117033
Closed Access | Times Cited: 17
Tongue squamous cell carcinoma-targeting Au-HN-1 nanosystem for CT imaging and photothermal therapy
Ming Hao, Xingchen Li, Xinxin Zhang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
Ming Hao, Xingchen Li, Xinxin Zhang, et al.
International Journal of Oral Science (2025) Vol. 17, Iss. 1
Open Access
PROTAC technology for prostate cancer treatment
Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Zhen Wang, Dingpeng Zhang, Hiroyuki Inuzuka, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines
Ziqin Yan, Xilin Lyu, Dongze Lin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115381-115381
Closed Access | Times Cited: 8
Ziqin Yan, Xilin Lyu, Dongze Lin, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115381-115381
Closed Access | Times Cited: 8
Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML
Rareş Drulă, Sabina Iluta, Diana Gulei, et al.
Blood Reviews (2022) Vol. 56, pp. 100971-100971
Open Access | Times Cited: 14
Rareş Drulă, Sabina Iluta, Diana Gulei, et al.
Blood Reviews (2022) Vol. 56, pp. 100971-100971
Open Access | Times Cited: 14
PROTACs in gastrointestinal cancers
Yu Chen, Qingfan Yang, Jinrun Xu, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 204-223
Open Access | Times Cited: 14
Yu Chen, Qingfan Yang, Jinrun Xu, et al.
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 204-223
Open Access | Times Cited: 14
PROTACs targeting epigenetic proteins
Chao Zhang, Yuna He, Xiuyun Sun, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 7
Chao Zhang, Yuna He, Xiuyun Sun, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 7
Development of visible-light-activatable photocaged PROTACs
Weizhi Weng, Gang Xue, Zhengying Pan
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116062-116062
Closed Access | Times Cited: 7
Weizhi Weng, Gang Xue, Zhengying Pan
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116062-116062
Closed Access | Times Cited: 7
Targeted Protein Degradation: Principles, Strategies, and Applications
Ting He, Chenxi Wen, Guodong Yang, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 4
Ting He, Chenxi Wen, Guodong Yang, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 4
Coumarin‐Derived Caging Groups in the Spotlight: Tailoring Physiochemical and Photophysical Properties
Megan R. Clotworthy, Joseph J. M. Dawson, Mark D. Johnstone, et al.
ChemPlusChem (2024)
Open Access | Times Cited: 1
Megan R. Clotworthy, Joseph J. M. Dawson, Mark D. Johnstone, et al.
ChemPlusChem (2024)
Open Access | Times Cited: 1
Discovery of novel 20S proteasome subunit β5 PROTAC degraders as potential therapeutics for pharyngeal carcinoma and Bortezomib-resistant multiple myeloma
Shumei Wang, Zhenzhen Li, Siyue Ma, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107801-107801
Closed Access | Times Cited: 1
Shumei Wang, Zhenzhen Li, Siyue Ma, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107801-107801
Closed Access | Times Cited: 1
Precise Modulation of Protein Degradation by Smart PROTACs
Junfei Cheng, Guoqiang Dong, Wei Wang, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 1
Junfei Cheng, Guoqiang Dong, Wei Wang, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 1